Institutional investors purchased a net $2.1 million shares of ADXS during the quarter ended April 2017. This may signal that the smart money is gaining interest in this company as the 50.95% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NEXTHERA CAPITAL LP Bought 155.2 Thousand shares of Advaxis Inc
THE VANGUARD GROUP, INC. Bought 120.0 Thousand shares of Advaxis Inc